Applying Interactive Mobile Health to Asthma Care in Teens (AIM2ACT)

Asthma Clinical Trial

— AIM2ACT  

Official title:

mHealth Approach to Collaborative Asthma Management for Teens & Parents

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02302040
• Other study ID #: IRB201400921 - N
• Secondary ID: 1R21HD083830-01A
• Status: Completed
• Phase: N/A
• Start date: December 2015
• Est. completion date: February 22, 2019

Study information

• Verified date: February 2021
• Source: University of Florida
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aims of this application are to develop and test AIM2ACT, a mobile health (mHealth) tool, delivered via smartphones, that fosters helpful caregiver support as early adolescents (ages 12-15) with persistent asthma develop and master asthma self-management behaviors. To facilitate helpful caregiver support, AIM2ACT uses mHealth technology to determine tailored intervention targets for each family. AIM2ACT then helps caregiver/adolescent dyads set asthma management goals by automatically guiding families through a structured process that includes the supportive behavioral management strategies of goal setting, contingency management, and problem solving communication. Skills-training videos for adolescents and caregivers provide guidance on how to complete each collaborative asthma management component.

AIM2ACT will be developed through feedback from an advisory board of adolescent-caregiver dyads from the target user population and a pediatric pulmonologist. Following advisory board feedback, the investigators will conduct a pilot randomized controlled trial of AIM2ACT with 50 early adolescents with poorly controlled asthma, ages 12-15 years, and a caregiver. Families will be randomly assigned to receive AIM2ACT or a self-guided condition for a 4 month intervention period. Participants in the self-guided condition will be given general information on supportive behavioral management techniques they can use to target improvement in asthma self-management behaviors. Outcomes include whether participants prefer AIM2ACT or the self-guided condition. Additionally, AIM2ACT and the self-guided condition will be compared to see if there are differences in changes in family asthma management (primary outcome), lung function, asthma control, asthma-related quality of life, and self-efficacy for asthma management. Data will be collected before participants are assigned to AIM2ACT or the self-guided control, post-treatment, and 4 month follow-up time points.

Description:

As a participant in the study the following will take place:

Questionnaires will be filled out which will include medical history, including asthma symptoms and control, and questions related to quality of life. In addition, an interview will be completed which assesses the participants asthma management.

During this visit a brief training on how to complete lung function testing with a portable device will be demonstrated. The participant will breathe into twice per day for 14 days and then the device will be collected at the end of the 14 day period.

Randomization A computer will randomly chose one of the two programs; Program A or Program B. Random assignment is like rolling a dice to decide which group a person is assigned to. Both Program A and B are 4 months in length.

Program A the participant will answer questions about asthma management for a one-week period on a smartphone program. A smartphone can be provided for the duration of the study. After the one-week period, a report will be received on the smartphone about areas of asthma management that are going well and areas that may be in need of improvement. Next, brief meetings with study personnel to help determine things that will help improve asthma management. This information will be entered into a smartphone program. The participant will continue to use the smartphone program for a four month period.

Program B the participant answer questions about asthma for a one-week period on a paper and pencil diary. The participant will receive a paper copy of feedback from study personnel related to areas of asthma management that are going well and areas that may be in need of improvement. The participant will then be given information on techniques they can use to target identified areas for improvement. The participant will be encouraged to use these strategies to for a 4 month period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 92
• Est. completion date: February 22, 2019
• Est. primary completion date: February 22, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 15 Years

Eligibility

Inclusion Criteria:

• Lives in residence of caregiver,

• adolescent meets screening criteria for current persistent asthma,

• adolescent has uncontrolled asthma as indicated by a score of = 19 on the Asthma Control Test,

• poorly controlled asthma according to National Heart, Lung, and Blood Institute (NHLBI) guidelines

• adolescent-caregiver dyad speak and read English

Exclusion Criteria:

• family is currently involved in an asthma management intervention, or

• adolescent has well controlled asthma as indicated by a score of = 20 on the Asthma Control Test.

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• AIM2ACT
AIM2ACT is a mobile health tool that is designed to facilitate collaborative asthma management between early adolescents and their caregivers.
• Self-guided
Paper feedback and collaborative asthma management strategies are provided to early adolescents and caregivers.

Locations

Country	Name	City	State
United States	Benton Pediactrics	Gainesville	Florida
United States	University of Florida	Gainesville	Florida

Sponsors (4)

Lead Sponsor	Collaborator
University of Florida	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Rhode Island Hospital, The Miriam Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Family asthma management system scale (FAMSS) will be measured for changes in baseline, 4 months, and 8 months.	Family Asthma Management System Scale (FAMSS) a validated family clinical interview that assesses core aspects of asthma management including medication adherence, symptom assessment and response, and integration of asthma into the family system.	Change in baseline, 4 months, and 8 months.
Secondary	Spirometry will be used to measure a change in lung function at baseline, 4 months, and 8 months.	Lung function will be measured with spirometry at baseline, 4 months, and 8 months between the two groups to determine if the use of the AIM2ACT mHealth platform improved symptoms.	Change in baseline, 4 months, and 8 months.
Secondary	Asthma control test questionnaire will be used to measure a change in symptoms at baseline, 4 months, and 8 months.	Asthma control test questionnaire will be used to measure a change in symptoms at baseline, 4 months, and 8 months.	Change in baseline, 4 months, and 8 months.
Secondary	Asthma-related quality of life questionnaires will be given to measure the overall quality of life changes in baseline, 4 months, and 8 months..	Asthma-related quality of life questionnaires will be given to measure the overall quality of life changes in baseline, 4 months, and 8 months.	Change in baseline, 4 months, and 8 months.
Secondary	Self-efficacy for asthma management questionnaire will be given to measure the overall improvement of the quality of life change in baseline, 4 months, and 8 months.	Asthma management efficacy questionnaire will be given to measure the overall improvement of the quality of life change in baseline, 4 months, and 8 months.	Change in baseline, 4 months, and 8 months.
Secondary	Family communication during asthma-management tasks will be assessed via the Decision Making Involvement Scale caregiver- and adolescent-reports at baseline and 4 months.	Family communication during asthma-management tasks will be assessed via the Decision Making Involvement Scale caregiver- and adolescent-reports at baseline and 4 months.	Change in baseline and 4 months